827 related articles for article (PubMed ID: 32153386)
21. Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis.
Haq I; Almulhem M; Soars S; Poulton D; Brodlie M
Pharmgenomics Pers Med; 2022; 15():91-104. PubMed ID: 35153502
[TBL] [Abstract][Full Text] [Related]
22. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
23. Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of
Ghelani DP; Schneider-Futschik EK
ACS Pharmacol Transl Sci; 2020 Feb; 3(1):4-10. PubMed ID: 32259083
[TBL] [Abstract][Full Text] [Related]
24. Gene Therapy: A Possible Alternative to CFTR Modulators?
Mercier J; Ruffin M; Corvol H; Guillot L
Front Pharmacol; 2021; 12():648203. PubMed ID: 33967785
[TBL] [Abstract][Full Text] [Related]
25. Triplet CFTR modulators: future prospects for treatment of cystic fibrosis.
Chaudary N
Ther Clin Risk Manag; 2018; 14():2375-2383. PubMed ID: 30584312
[TBL] [Abstract][Full Text] [Related]
26. Improving outcomes of infections in cystic fibrosis in the era of CFTR modulator therapy.
Saiman L
Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S18-S26. PubMed ID: 31715086
[TBL] [Abstract][Full Text] [Related]
27. Cystic Fibrosis Transmembrane Regulator Modulators: Implications for the Management of Depression and Anxiety in Cystic Fibrosis.
Talwalkar JS; Koff JL; Lee HB; Britto CJ; Mulenos AM; Georgiopoulos AM
Psychosomatics; 2017; 58(4):343-354. PubMed ID: 28576305
[TBL] [Abstract][Full Text] [Related]
28. CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease.
Fernandez Fernandez E; De Santi C; De Rose V; Greene CM
Expert Rev Respir Med; 2018 Jun; 12(6):483-492. PubMed ID: 29750581
[TBL] [Abstract][Full Text] [Related]
29. Cystic fibrosis: toward personalized therapies.
Ikpa PT; Bijvelds MJ; de Jonge HR
Int J Biochem Cell Biol; 2014 Jul; 52():192-200. PubMed ID: 24561283
[TBL] [Abstract][Full Text] [Related]
30. CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis.
Taylor-Cousar JL
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32825766
[TBL] [Abstract][Full Text] [Related]
31. Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment.
Rogan MP; Stoltz DA; Hornick DB
Chest; 2011 Jun; 139(6):1480-1490. PubMed ID: 21652558
[TBL] [Abstract][Full Text] [Related]
32. Personalized medicine in cystic fibrosis: dawning of a new era.
Clancy JP; Jain M
Am J Respir Crit Care Med; 2012 Oct; 186(7):593-7. PubMed ID: 22723294
[TBL] [Abstract][Full Text] [Related]
33. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
Pettit RS
Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
[TBL] [Abstract][Full Text] [Related]
34. Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine.
Pranke I; Golec A; Hinzpeter A; Edelman A; Sermet-Gaudelus I
Front Pharmacol; 2019; 10():121. PubMed ID: 30873022
[TBL] [Abstract][Full Text] [Related]
35. New drugs in cystic fibrosis: what has changed in the last decade?
Roda J; Pinto-Silva C; Silva IAI; Maia C; Almeida S; Ferreira R; Oliveira G
Ther Adv Chronic Dis; 2022; 13():20406223221098136. PubMed ID: 35620188
[TBL] [Abstract][Full Text] [Related]
36. New treatments targeting the basic defects in cystic fibrosis.
Fajac I; Wainwright CE
Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
[TBL] [Abstract][Full Text] [Related]
37. Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy.
Tewkesbury DH; Robey RC; Barry PJ
Breathe (Sheff); 2021 Dec; 17(4):210112. PubMed ID: 35035569
[TBL] [Abstract][Full Text] [Related]
38. Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis.
Silva IAL; Laselva O; Lopes-Pacheco M
J Pers Med; 2022 Aug; 12(8):. PubMed ID: 36013270
[TBL] [Abstract][Full Text] [Related]
39. New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.
Ong T; Ramsey BW
Pediatr Clin North Am; 2016 Aug; 63(4):751-64. PubMed ID: 27469186
[TBL] [Abstract][Full Text] [Related]
40. Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis.
Graeber SY; Vitzthum C; Mall MA
J Pers Med; 2021 May; 11(5):. PubMed ID: 34066648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
